Cargando…
Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer’s Disease
The blood–brain barrier (BBB) restricts entry of neurotoxic plasma components, blood cells, and pathogens into the brain, leading to proper neuronal functioning. BBB impairment leads to blood-borne protein infiltration such as prothrombin, thrombin, prothrombin kringle-2, fibrinogen, fibrin, and oth...
Autores principales: | Kim, Sehwan, Sharma, Chanchal, Jung, Un Ju, Kim, Sang Ryong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216844/ https://www.ncbi.nlm.nih.gov/pubmed/37239054 http://dx.doi.org/10.3390/biomedicines11051383 |
Ejemplares similares
-
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease
por: Sharma, Chanchal, et al.
Publicado: (2021) -
pKr-2 induces neurodegeneration via upregulation of microglial TLR4 in the hippocampus of AD brain
por: Kim, Sehwan, et al.
Publicado: (2023) -
Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
por: Sharma, Chanchal, et al.
Publicado: (2022) -
Mesenchymal Stem Cell Transplantation Ameliorates Ara-C-Induced Motor Deficits in a Mouse Model of Cerebellar Ataxia
por: Park, Narae, et al.
Publicado: (2023) -
Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
por: Sharma, Chanchal, et al.
Publicado: (2021)